Oglobe M 500mg/0.2mg Tablet SR
Marketer
Cian Health Care Pvt Ltd
Salt Composition
Metformin (500mg) + Voglibose (0.2mg)
Overview Oglobe M 500mg/0.2mg Tablet SR
Diabetics using Oglobe M 500mg/0.2mg SR tablets, an anti-diabetic combination medication, manage type 2 diabetes in adults. This medication regulates blood glucose. Administer Oglobe M with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as advised by your doctor. Lifestyle choices significantly influence diabetes control. Possible side effects – nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes – are generally transient. Persistent or concerning side effects warrant medical attention. Your physician can provide management strategies. Contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose prior heart conditions before commencing treatment. Pregnant or lactating individuals should seek medical counsel before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.
Primary Ingredients of Oglobe M 500mg/0.2mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Oglobe M 500mg/0.2mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Oglobe M 500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Oglobe M 500mg/0.2mg Tablet SR whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Oglobe M 500mg/0.2mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Oglobe M 500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Oglobe M 500mg/0.2mg Extended-Release Tablet with food.
How Oglobe M 500mg/0.2mg Tablet SR works:
Extended-release Oglobe M tablets (500mg/0.2mg) contain a dual-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Oglobe M 500mg/0.2mg Tablet SR is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Oglobe M 500mg/0.2mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Sustained-release Oglobe M 500mg/0.2mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Oglobe M 500mg/0.2mg SR tablets. Nevertheless, patients using this medication concurrently with other blood sugar-lowering drugs, including sulfonylureas, insulin, or repaglinide, should be aware of the potential for low blood sugar.
KidneyCAUTION
Patients with kidney impairment should use Oglobe M 500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.
LiverCONSULT YOUR DOCTOR
Data regarding the use of Oglobe M 500mg/0.2mg sustained-release tablets in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Oglobe M 500mg/0.2mg Tablet SR :
Should you forget a dose of Oglobe M 500mg/0.2mg Extended-Release Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Oglobe M 500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently